Cs 2 CO 3 ‐Promoted Alkylation of 3‐Cyano‐2(1 H )‐Pyridones: Anticancer Evaluation and Molecular Docking
ChemPlusChem · 2024
DOI: 10.1002/cplu.202400172 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemPlusChem, 2024. Verfasst von Kevin Salamanca-Perdigón und 6 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Ciencias Químicas, Universidad Pedagógica y Tecnológica de Colombia, Tunja, 150003, Colombia. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Pyridones, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: Dirección de Investigaciones at the Universidad Pedagógica y Tecnológica de Colombia, Facultad de Ciencias at the Universidad de los Andes, Universidad de Alcalá.
Abstract (Originalsprache)
Herein, a Cs 2 CO 3 ‐promoted N ‐alkylation of 3‐cyano‐2(1 H )‐pyridones containing alkyl groups with diverse alkyl halides to synthesize N ‐alkyl‐2‐pyridones over O ‐alkylpyridines is reported. The use of alkyl dihalides resulted in complex mixtures of N ‐ and O ‐alkylated products. The primary factor influencing regioselectivity in these reactions is the electronic effects of substituents on the 2(1 H )‐pyridone ring, as evidenced by the preferential formation of O ‐alkylpyridines upon the introduction of aryl groups. Remarkably, we efficiently employed CuAAC and Ti(O i ‐Pr) 4 ‐catalyzed amidation reactions to functionalize N ‐alkyl‐2‐pyridones containing propargyl and ester groups, leading to the synthesis of 1,2,3‐triazoles and amides, respectively. Moreover, O ‐alkylpyridines 10 b and 10 d displayed remarkable selectivity toward the A‐498 renal cancer cell line with growth inhibition percentages (%GI) of 54.75 and 67.64, respectively. The binding modes of compounds 10 b and 10 d to the PIM‐1 kinase enzyme were determined through molecular docking studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Escuela de Ciencias Químicas, Universidad Pedagógica y Tecnológica de Colombia, Tunja, 150003, Colombia.
- Bioorganic Compounds Research Group, Department of Chemistry, Universidad de los Andes, Carrera 1 No. 18 A-10, Bogota, 111711, Colombia.
- Departamento de Química Orgánica y Química Inorgánica, Ctra. Madrid-Barcelona, Universidad de Alcalá, Km. 33, 6, 28871, Madrid, Spain.
- Institute of Chemical Research Andrés M. del Río, Universidad de Alcalá, Alcalá de Henares, 28805, Madrid, Spain.
ORCID-Profile: Jaime Portilla, Hugo Rojas, Diana Becerra, Juan-Carlos Castillo
Förderung
- Dirección de Investigaciones at the Universidad Pedagógica y Tecnológica de Colombia
- Facultad de Ciencias at the Universidad de los Andes
- Universidad de Alcalá
- National Cancer Institute (NCI, USA)
Zitieren
APA
Salamanca-Perdigón, K., Hurtado-Rodríguez, D., Portilla, J., Iriepa, I., Rojas, H., Becerra, D., & Castillo, J. C. (2024). Cs 2 CO 3 ‐Promoted Alkylation of 3‐Cyano‐2(1 H )‐Pyridones: Anticancer Evaluation and Molecular Docking. ChemPlusChem. https://doi.org/10.1002/cplu.202400172
Vancouver
Salamanca-Perdigón K, Hurtado-Rodríguez D, Portilla J, Iriepa I, Rojas H, Becerra D, et al. Cs 2 CO 3 ‐Promoted Alkylation of 3‐Cyano‐2(1 H )‐Pyridones: Anticancer Evaluation and Molecular Docking. ChemPlusChem. 2024. doi:10.1002/cplu.202400172
BibTeX
@article{SalamancaPerdign2024,
author = {Salamanca-Perdigón, Kevin and Hurtado-Rodríguez, Diana and Portilla, Jaime and Iriepa, Isabel and Rojas, Hugo and Becerra, Diana and Castillo, Juan-Carlos},
title = {Cs 2 CO 3 ‐Promoted Alkylation of 3‐Cyano‐2(1 H )‐Pyridones: Anticancer Evaluation and Molecular Docking},
journal = {ChemPlusChem},
year = {2024},
doi = {10.1002/cplu.202400172}
}
EUVIMED